| A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) (NCT00863525) | Merck Sharp & Dohme LLC | 2004-11-01 |
| The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin (NCT00665613) | Northwell Health | 2004-10-01 |
| Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120) (NCT00120757) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-10-01 |
| Effects of DHEA/Exercise on Bone, Muscle and Balance (NCT00664053) | National Aeronautics and Space Administration (NASA) | 2004-10-01 |
| The Genetic and Life Style Determinants of Bone Mass of Young Greek Males (NCT00449215) | University of Athens | 2004-10-01 |
| A New Active Vitamin D, ED-71 for Osteoporosis (NCT00144456) | Chugai Pharmaceutical | 2004-09-01 |
| Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038) (NCT00139438) | Merck Sharp & Dohme LLC | 2004-09-01 |
| Zoledronate for Osteopenia in Pediatric Crohn's (NCT00798473) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2004-09-01 |
| Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002) (NCT00769418) | Merck Sharp & Dohme LLC | 2004-09-01 |
| Quantitative Diffusion and Fat Imaging of the Spine (NCT00498277) | M.D. Anderson Cancer Center | 2004-08-01 |
| Adding Phosphorus to Osteoporosis Drug Treatment (NCT00074711) | Creighton University | 2004-08-01 |
| A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis (NCT00089791) | Amgen | 2004-08-01 |
| Teriparatide Use in Hip Replaced Subjects (NCT00191321) | Eli Lilly and Company | 2004-07-01 |
| Comparison of Osteoporosis Disease Management Strategies (0000-039) (NCT00145080) | Merck Sharp & Dohme LLC | 2004-07-01 |
| Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis (NCT00100620) | Novartis Pharmaceuticals | 2004-06-01 |
| A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate (NCT00100555) | Novartis Pharmaceuticals | 2004-06-01 |
| Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis. (NCT00202956) | Taichung Veterans General Hospital | 2004-06-01 |
| Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation (NCT00143273) | Ligand Pharmaceuticals | 2004-06-01 |
| A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers (NCT00863590) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 (NCT00369850) | ETOP IBCSG Partners Foundation | 2004-05-01 |
| Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid (NCT00097812) | Novartis Pharmaceuticals | 2004-05-01 |
| Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density (NCT00114270) | University of Virginia | 2004-05-01 |
| 4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230) (NCT00641771) | Organon and Co | 2004-05-01 |
| Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women (NCT00086619) | Massachusetts General Hospital | 2004-05-01 |
| Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men (NCT00097825) | Novartis Pharmaceuticals | 2004-04-01 |
| Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. (NCT00104572) | National Institute on Aging (NIA) | 2004-03-01 |
| Percutaneous Vertebroplasty Versus Conservative Treatment of Pain (NCT00203554) | University of Aarhus | 2004-03-01 |
| Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis (NCT00100607) | Novartis Pharmaceuticals | 2004-02-01 |
| Calcium Supplementation in Postmenopausal Women (NCT00172172) | Shire | 2004-01-10 |
| Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI (NCT01140321) | Ente Ospedaliero Ospedali Galliera | 2004-01-01 |
| Osteoporosis and Dental Implant (NCT00727493) | Charite University, Berlin, Germany | 2004-01-01 |
| Education for Osteoporosis in Persons With Existing Fractures (NCT00575250) | University of Adelaide | 2004-01-01 |
| Glucocorticoids Promote Osteoclast Survival (NCT00572299) | University of Arkansas | 2004-01-01 |
| A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) (NCT00092079) | Merck Sharp & Dohme LLC | 2004-01-01 |
| The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment (NCT00372372) | Tuen Mun Hospital | 2004-01-01 |
| Effect of Soy Bread on Markers of Bone Metabolism and Cardiovascular Disease (NCT00366860) | University of Michigan | 2004-01-01 |
| Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis (NCT01611571) | Columbia University | 2003-12-01 |
| Once Weekly Parathyroid Hormone for Osteoporosis (NCT00065637) | University of California, San Francisco | 2003-12-01 |
| Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients (NCT00157690) | McMaster University | 2003-12-01 |
| Osteoporosis Disease Management Demonstration Project (0000-040) (NCT00145067) | Merck Sharp & Dohme LLC | 2003-11-01 |
| Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis (NCT00259857) | Medical University of South Carolina | 2003-10-01 |
| Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy (NCT00129142) | GTx | 2003-10-01 |
| A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth (NCT00069004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women (NCT03822078) | Amgen | 2003-09-30 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) (NCT00092066) | Organon and Co | 2003-09-24 |
| Outcomes of Sleep Disorders in Older Men (NCT00070681) | National Heart, Lung, and Blood Institute (NHLBI) | 2003-09-01 |
| Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients (NCT00191802) | Eli Lilly and Company | 2003-09-01 |
| Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms (NCT00076050) | University of Miami | 2003-09-01 |
| Strategies Targeting Osteoporosis to Prevent Recurrent Fractures (NCT00152321) | University of Alberta | 2003-09-01 |
| Optimal Management of Women With Wrist Fractures (NCT00226031) | Queen's University | 2003-09-01 |
| Bone Effects of Teriparatide Following Alendronate (NCT00191893) | Eli Lilly and Company | 2003-09-01 |
| Patient- and Physician-Based Osteoporosis Education (NCT00073190) | Brigham and Women's Hospital | 2003-09-01 |
| An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass (NCT00078026) | Genzyme, a Sanofi Company | 2003-08-01 |
| Study of FORTEO Use in Subjects in the Community Setting (NCT01078805) | Eli Lilly and Company | 2003-08-01 |
| Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer (NCT00176579) | University of Medicine and Dentistry of New Jersey | 2003-06-01 |
| Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme (NCT00359047) | CHU de Quebec-Universite Laval | 2003-06-01 |
| Preventive Effect of H.Pylori Eradication on Osteoporosis (NCT06818591) | Seoul National University Bundang Hospital | 2003-05-01 |
| A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D (NCT00806416) | Organon and Co | 2003-05-01 |
| Osteoporosis Disease Management Demonstration Project (0000-037) (NCT00139425) | Merck Sharp & Dohme LLC | 2003-05-01 |
| Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss (NCT00163137) | Ligand Pharmaceuticals | 2003-05-01 |
| Vertebroplasty for the Treatment of Fractures Due to Osteoporosis (NCT00068822) | Mayo Clinic | 2003-04-01 |
| Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate (NCT00837746) | Warner Chilcott | 2003-04-01 |
| Bone Mineral Density (BMD) in HIV Infection (NCT00146094) | University Hospital, Strasbourg, France | 2003-03-01 |
| Therapeutic Touch for Wrist Fractures in Postmenopausal Women (NCT00079521) | National Center for Complementary and Integrative Health (NCCIH) | 2003-03-01 |
| Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation (NCT00058188) | Northwestern University | 2003-03-01 |
| Bone Response to Soy Isoflavones in Women (NCT00043745) | Iowa State University | 2003-03-01 |
| Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer (NCT00054418) | Alliance for Clinical Trials in Oncology | 2003-03-01 |
| FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study (NCT00465387) | Group Health Centre | 2003-03-01 |
| Five-Year CT Follow-Up of Vertebral Fracture Risk Using Opportunistic Osteoporosis Screening (NCT07487688) | Technical University of Munich | 2003-02-25 |
| Effects of Tibolone Treatment on the Endometrium (NCT00294463) | Erasmus Medical Center | 2003-02-01 |
| FREE Study - Fracture Reduction Evaluation (NCT00211211) | Medtronic Spine LLC | 2003-02-01 |
| Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS (NCT00324714) | ETOP IBCSG Partners Foundation | 2003-02-01 |
| Research on Aging Project in Iceland: Second Stage (NCT01322568) | National Institute on Aging (NIA) | 2003-01-31 |
| The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture. (NCT00346190) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2003-01-01 |
| Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis (NCT00051558) | Eli Lilly and Company | 2002-11-01 |
| Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose (NCT00577850) | Warner Chilcott | 2002-11-01 |
| Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer (NCT00043069) | Alliance for Clinical Trials in Oncology | 2002-11-01 |
| Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women (NCT00301353) | TNO | 2002-10-01 |
| Treatment of Low Bone Density in Cystic Fibrosis. (NCT01812551) | Istituto Auxologico Italiano | 2002-10-01 |
| Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy (NCT00050011) | Novartis Pharmaceuticals | 2002-09-01 |
| OSTPRE-Fracture Prevention Study (NCT00592917) | Kuopio University Hospital | 2002-08-01 |
| Dynamic Magnetic Resonance (MR) Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related Research (NCT00172224) | National Taiwan University Hospital | 2002-08-01 |
| Network Osteoporosis Study (NCT00209469) | Glaser Pediatric Research Network | 2002-07-01 |
| Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy (NCT00616694) | Sanofi | 2002-07-01 |
| Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women (NCT00043719) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2002-07-01 |
| Bone Adaptation to Impact Loading (NCT00697957) | University of Oulu | 2002-05-01 |
| Prevention of Osteoporosis in Men With Prostate Cancer (NCT00048841) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2002-05-01 |
| The Importance of Patient Education - A Randomised Controlled Trial (NCT00414154) | Odense University Hospital | 2002-05-01 |
| Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation (NCT00302484) | Medical University of Vienna | 2002-04-01 |
| Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women (NCT00675688) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-04-01 |
| Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer (NCT00079248) | Institute of Cancer Research, United Kingdom | 2002-03-01 |
| Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients (NCT00175175) | University of Alberta | 2002-03-01 |
| The Effect of Vitamin K2 on Bone Turnover (NCT00548509) | Eisai Limited | 2002-02-01 |
| Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture (NCT00046254) | Novartis Pharmaceuticals | 2002-02-01 |
| Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients (NCT00136058) | University of Alberta | 2002-01-01 |
| Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis (NCT00154609) | National Taiwan University Hospital | 2002-01-01 |
| HORIZON-PFT: Pivotal Fracture Trial (NCT00049829) | Novartis Pharmaceuticals | 2002-01-01 |
| Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer (NCT00022087) | Alliance for Clinical Trials in Oncology | 2001-12-01 |
| Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women (NCT00205777) | Pfizer | 2001-12-01 |
| Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL) (NCT00141323) | Ligand Pharmaceuticals | 2001-11-01 |